Ultragenyx Pharmaceutical Inc. (52) | Uncategorized (6)

Recent Contracts

Open Market Sale Agreement, dated May 7, 2021, by and between Ultragenyx Pharmaceutical Inc. and Jefferies LLC (Filed With SEC on May 7, 2021)
Amendment dated October 9, 2020 to the Offer Letter between Mardi C. Dier and Ultragenyx Pharmaceutical Inc. dated August 28, 2020 (Filed With SEC on October 13, 2020)
Offer Letter between Mardi C. Dier and Ultragenyx Pharmaceutical Inc. dated August 28, 2020 (Filed With SEC on September 2, 2020)
Offer Letter, dated May 16, 2017, by and between Ultragenyx Pharmaceutical Inc. and Erik Harris (Filed With SEC on August 2, 2019)
Addendum #1, dated August 8, 2017, to Offer Letter dated May 16, 2017 between Ultragenyx Pharmaceutical Inc. and Erik Harris (Filed With SEC on August 2, 2019)
Addendum #2, dated June 19, 2019, to Offer Letter dated May 16, 2017 between Ultragenyx Pharmaceutical Inc. and Erik Harris (Filed With SEC on August 2, 2019)